谷歌浏览器插件
订阅小程序
在清言上使用

DOP15 Results of a Pragmatic Multicentred Randomised Controlled Trial Investigating the Use of Personalised Golimumab Dosing in Ulcerative Colitis: the GOAL-ARC Study (GLM Dose Optimisation to Adequate Levels to Achieve Response in Colitis)

JOURNAL OF CROHNS & COLITIS(2024)

引用 0|浏览9
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要